tiprankstipranks
Trending News
More News >
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
Advertisement

VYNE Therapeutics (VYNE) Technical Analysis

Compare
1,858 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
VYNE Therapeutics’s (VYNE) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting VYNE Therapeutics is a Buy.
VYNE Therapeutics’s (VYNE) 20-Day exponential moving average is 1.24, while VYNE Therapeutics’s (VYNE) share price is $0.4, making it a Sell.
VYNE Therapeutics’s (VYNE) 50-Day exponential moving average is 1.28, while VYNE Therapeutics’s (VYNE) share price is $0.4, making it a Sell.

VYNE Therapeutics (VYNE) Pivot Points

Aug 01, 2025, 06:29 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.29
1.34
1.39
1.44
1.49
1.54
1.59
Fibonacci
1.34
1.38
1.40
1.44
1.48
1.50
1.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

VYNE Therapeutics (VYNE) Moving Averages

Aug 01, 2025, 06:29 AM
Period
Simple
Exponential
MA5
1.22Sell
1.07Sell
MA10
1.22Sell
1.19Sell
MA20
1.30Sell
1.24Sell
MA50
1.17Sell
1.28Sell
MA100
1.39Sell
1.46Sell
MA200
2.05Sell
1.82Sell
VYNE Therapeutics’s (VYNE) 10-Day exponential moving average is 1.19, while VYNE Therapeutics’s (VYNE) share price is $0.4, making it a Sell.
VYNE Therapeutics’s (VYNE) 100-Day exponential moving average is 1.46, while VYNE Therapeutics’s (VYNE) share price is $0.4, making it a Sell.
VYNE Therapeutics’s (VYNE) stock price is $0.4 and VYNE Therapeutics’s (VYNE) 50-day simple moving average is 1.17, creating a Sell signal.
VYNE Therapeutics’s (VYNE) stock price is $0.4 and VYNE Therapeutics’s (VYNE) 100-day simple moving average is 1.39, creating a Sell signal.
VYNE Therapeutics’s (VYNE) stock price is $0.4 and VYNE Therapeutics’s (VYNE) 200-day simple moving average is 2.05, creating a Sell signal.

VYNE Therapeutics (VYNE) Technical Indicators

Aug 01, 2025, 06:29 AM
Name
Value
Implied Action
RSI (14)
29.11
Buy
STOCH (9,6)
47.54
Neutral
STOCHRSI (14)
47.54
Neutral
MACD (12,26)
-0.04
Buy
ADX (14)
25.07
Neutral
Williams %R
-96.76
Buy
CCI (14)
-438.94
Buy
ATR (14)
0.23
-
Ultimate Oscillator
31.46
Neutral
ROC
-71.01
Sell
VYNE Therapeutics’s (VYNE) Relative Strength Index (RSI) is 29.11, creating a Buy signal.
VYNE Therapeutics’s (VYNE) Trend Strength Indicator (ADX) is 25.07, creating a Neutral signal.
VYNE Therapeutics’s (VYNE) Commodity Channel Index (CCI) is -438.94, creating a Buy signal.
VYNE Therapeutics’s (VYNE) Price Rate of Change (ROC) is -71.01, creating a Sell signal.

FAQ

Is VYNE a Buy, Hold, or Sell?
Based on VYNE’s technical indicators, VYNE is a Sell.
    What is VYNE’s RSI (14)?
    VYNE’s RSI (14) is 29.11, which suggests VYNE is a Buy.
      What is VYNE’s MACD?
      VYNE’s MACD is -0.04, which suggests VYNE is a Buy.
        What is VYNE’s 5-day moving average?
        VYNE’s 5-day moving average is 1.22, which suggests VYNE is a Sell.
          What is VYNE’s 20-day moving average?
          VYNE 20-day moving average is 1.30, which suggests VYNE is a Sell.
            What is VYNE’s 50-day moving average?
            VYNE’s 50-day moving average is 1.17, which suggests VYNE is a Sell.
              What is VYNE’s 200-day moving average?
              VYNE’s 200-day moving average is 2.05, which suggests VYNE is a Sell.
                What is VYNE’s Williams % R (14)?
                VYNE’s Williams % R (14) is -96.76, which suggests VYNE is a Buy.
                  What is VYNE’s CCI (14)?
                  VYNE’s CCI (14) is -438.94, which suggests VYNE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis